Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.

Papaioannou AI, Konstantelou E, Papaporfyriou A, Bartziokas K, Spathis A, Bakakos P, Loukides S, Koulouris N, Papiris S, Kostikas K.

Lung. 2018 Feb 14. doi: 10.1007/s00408-018-0099-5. [Epub ahead of print]

PMID:
29445934
2.

Targeted anti-IL-13 therapies in asthma: current data and future perspectives.

Ntontsi P, Papathanassiou E, Loukides S, Bakakos P, Hillas G.

Expert Opin Investig Drugs. 2018 Feb;27(2):179-186. doi: 10.1080/13543784.2018.1427729. Epub 2018 Jan 19. Review.

PMID:
29334288
3.

Exhaled breath temperature in optimally treated asthmatics: severity and underlying mechanisms.

Ntontsi P, Bakakos P, Papathanasiou E, Tsilogianni Z, Kostikas K, Hillas G, Papatheodorou G, Koulouris NG, Papiris S, Loukides S.

J Breath Res. 2017 Nov 27. doi: 10.1088/1752-7163/aa9d46. [Epub ahead of print]

PMID:
29176061
4.

Emphysematous Phenotype is Characterized by Low Blood Eosinophils: A Cross-Sectional Study.

Papaioannou AI, Kostikas K, Papaporfyriou A, Angelakis L, Papathanasiou E, Hillas G, Mazioti A, Bakakos P, Koulouris N, Papiris S, Loukides S.

COPD. 2017 Dec;14(6):635-640. doi: 10.1080/15412555.2017.1386644. Epub 2017 Nov 3.

PMID:
29099646
5.

The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis.

Tsikrika S, Dimakou K, Papaioannou AI, Hillas G, Thanos L, Kostikas K, Loukides S, Papiris S, Koulouris N, Bakakos P.

Cytokine. 2017 Nov;99:281-286. doi: 10.1016/j.cyto.2017.08.005. Epub 2017 Aug 31.

PMID:
28863927
6.

Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.

Petta V, Perlikos F, Loukides S, Bakakos P, Chalkias A, Iacovidou N, Xanthos T, Tsekoura D, Hillas G.

Heart Fail Rev. 2017 Nov;22(6):753-763. doi: 10.1007/s10741-017-9646-z. Review.

PMID:
28840400
7.

Serum periostin in patients hospitalized for COPD exacerbations.

Konstantelou E, Papaioannou AI, Loukides S, Bartziokas K, Papaporfyriou A, Papatheodorou G, Bakakos P, Papiris S, Koulouris N, Kostikas K.

Cytokine. 2017 May;93:51-56. doi: 10.1016/j.cyto.2017.05.007. Epub 2017 May 13.

PMID:
28511944
8.

Direct and Indirect Costs of Asthma Management in Greece: An Expert Panel Approach.

Souliotis K, Kousoulakou H, Hillas G, Bakakos P, Toumbis M, Loukides S, Vassilakopoulos T.

Front Public Health. 2017 Apr 5;5:67. doi: 10.3389/fpubh.2017.00067. eCollection 2017.

9.

Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes.

Ntontsi P, Loukides S, Bakakos P, Kostikas K, Papatheodorou G, Papathanassiou E, Hillas G, Koulouris N, Papiris S, Papaioannou AI.

Allergy. 2017 Nov;72(11):1761-1767. doi: 10.1111/all.13184. Epub 2017 May 11.

PMID:
28407269
10.

The association between serum periostin and a type 2 helper airway composite index in optimally treated asthmatics.

Konstantellou E, Loukides S, Ntontsi P, Papathanasiou E, Kostikas K, Paptheodorou G, Hillas G, Papiris S, Koulouris NG, Bakakos P.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1129-1131.e3. doi: 10.1016/j.jaip.2017.03.005. Epub 2017 Apr 7. No abstract available.

PMID:
28396112
11.

Effect of pulmonary rehabilitation on tidal expiratory flow limitation at rest and during exercise in COPD patients.

Theodorakopoulou EP, Gennimata SA, Harikiopoulou M, Kaltsakas G, Palamidas A, Koutsoukou A, Roussos C, Kosmas EN, Bakakos P, Koulouris NG.

Respir Physiol Neurobiol. 2017 Apr;238:47-54. doi: 10.1016/j.resp.2017.01.008. Epub 2017 Jan 18.

PMID:
28109942
12.

Temporal evolution of thoracocentesis-induced changes in spirometry and respiratory muscle pressures.

Michaelides SA, Bablekos GD, Analitis A, Ionas G, Bakakos P, Charalabopoulos KA.

Postgrad Med J. 2017 Aug;93(1102):460-464. doi: 10.1136/postgradmedj-2016-134268. Epub 2017 Jan 5.

PMID:
28057838
13.

Severe asthma: anti-IgE or anti-IL-5?

Papathanassiou E, Loukides S, Bakakos P.

Eur Clin Respir J. 2016 Nov 7;3:31813. doi: 10.3402/ecrj.v3.31813. eCollection 2016. Review.

14.

Activin A and follistatin in patients with asthma. Does severity make the difference?

Papaporfyriou A, Bakakos P, Kostikas K, Papatheodorou G, Hillas G, Trigidou R, Katafigiotis P, Koulouris NG, Papiris SA, Loukides S.

Respirology. 2017 Apr;22(3):473-479. doi: 10.1111/resp.12937. Epub 2016 Nov 2.

PMID:
27807906
15.

Sputum interleukin-13 as a biomarker for the evaluation of asthma control.

Tsilogianni Z, Hillas G, Bakakos P, Aggelakis L, Konstantellou E, Papaioannou AI, Papaporfyriou A, Papiris S, Koulouris N, Loukides S, Kostikas K.

Clin Exp Allergy. 2016 Nov;46(11):1498. doi: 10.1111/cea.12825. No abstract available.

PMID:
27790845
16.

Quantitative computed tomography: what does airway obstruction look-like?

Kallieri M, Papaioannou AI, Kostikas K, Bakakos P, Loukides S.

J Thorac Dis. 2016 Sep;8(9):E1044-E1046. No abstract available.

17.

Prolonged occupational exposure leads to allergic airway sensitization and chronic airway and systemic inflammation in professional firefighters.

Gianniou N, Katsaounou P, Dima E, Giannakopoulou CE, Kardara M, Saltagianni V, Trigidou R, Kokkini A, Bakakos P, Markozannes E, Litsiou E, Tsakatikas A, Papadopoulos C, Roussos C, Koulouris N, Rovina N.

Respir Med. 2016 Sep;118:7-14. doi: 10.1016/j.rmed.2016.07.006. Epub 2016 Jul 13.

PMID:
27578465
18.

Predictors of future exacerbation risk in patients with asthma.

Papaioannou AI, Kostikas K, Bakakos P, Papaporfyriou A, Konstantellou E, Hillas G, Papatheodorou G, Koulouris NG, Papiris S, Loukides S.

Postgrad Med. 2016 Sep;128(7):687-92. doi: 10.1080/00325481.2016.1220807. Epub 2016 Aug 17.

PMID:
27494758
19.

Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients.

Dimakou K, Triantafillidou C, Toumbis M, Tsikritsaki K, Malagari K, Bakakos P.

Respir Med. 2016 Jul;116:1-7. doi: 10.1016/j.rmed.2016.05.001. Epub 2016 May 3.

PMID:
27296814
20.

Biomarkers Guided Treatment Strategies in Adult Patients with Asthma: Ready for the Clinical Field?

Tsilogianni Z, Ntontsi P, Papaioannou AI, Bakakos P, Loukides S.

Arch Immunol Ther Exp (Warsz). 2017 Feb;65(1):1-9. doi: 10.1007/s00005-016-0407-9. Epub 2016 Jun 8. Review.

PMID:
27271573
21.

Sputum interleukin-13 as a biomarker for the evaluation of asthma control.

Tsilogianni Z, Hillas G, Bakakos P, Aggelakis L, Konstantellou E, Papaioannou AI, Papaporfyriou A, Papiris S, Koulouris N, Loukides S, Kostikas K.

Clin Exp Allergy. 2016 Jul;46(7):923-31. doi: 10.1111/cea.12729. Epub 2016 May 3. Erratum in: Clin Exp Allergy. 2016 Nov;46(11):1498.

PMID:
26990030
22.

Fever and multilobular mass of the right lung in a young adult with asthma.

Sotiriou A, Koulouris N, Bakakos P.

Med Mycol Case Rep. 2015 Dec 5;10:7-10. doi: 10.1016/j.mmcr.2015.12.001. eCollection 2015 Dec.

23.

Changes in BODE Quartiles After Pulmonary Rehabilitation Do Not Predict 2-Year Survival in Patients With COPD.

Kavoura P, Kostikas K, Tselebis A, Bratis D, Kosmas E, Alchanatis M, Koulouris NG, Bakakos P, Loukides S.

J Cardiopulm Rehabil Prev. 2016 Jan-Feb;36(1):62-7. doi: 10.1097/HCR.0000000000000157.

PMID:
26629865
24.

Smoking asthma phenotype: diagnostic and management challenges.

Bakakos P, Kostikas K, Loukides S.

Curr Opin Pulm Med. 2016 Jan;22(1):53-8. doi: 10.1097/MCP.0000000000000221. Review.

PMID:
26606078
25.

Biomarkers in the Management of Chronic Lung Disease.

Kostikas K, Loukides S, Bakakos P.

Curr Top Med Chem. 2016;16(14):1537-8. No abstract available.

PMID:
26510585
26.

Vascular Biomarkers in Asthma and COPD.

Bakakos P, Patentalakis G, Papi A.

Curr Top Med Chem. 2016;16(14):1599-609. Review.

PMID:
26420364
27.

Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype.

Konstantellou E, Papaioannou AI, Loukides S, Patentalakis G, Papaporfyriou A, Hillas G, Papiris S, Koulouris N, Bakakos P, Kostikas K.

Respir Med. 2015 Nov;109(11):1404-9. doi: 10.1016/j.rmed.2015.09.009. Epub 2015 Sep 21.

28.

Low interleukin (IL)-18 levels in sputum supernatants of patients with severe refractory asthma.

Rovina N, Dima E, Bakakos P, Tseliou E, Kontogianni K, Papiris S, Koutsoukou A, Koulouris NG, Loukides S.

Respir Med. 2015 May;109(5):580-7. doi: 10.1016/j.rmed.2015.03.002. Epub 2015 Mar 19.

29.

Sputum and BAL Clara cell secretory protein and surfactant protein D levels in asthma.

Emmanouil P, Loukides S, Kostikas K, Papatheodorou G, Papaporfyriou A, Hillas G, Vamvakaris I, Triggidou R, Katafigiotis P, Kokkini A, Papiris S, Koulouris N, Bakakos P.

Allergy. 2015 Jun;70(6):711-4. doi: 10.1111/all.12603. Epub 2015 Mar 18.

30.

Angiopoietins 1 and 2 in sputum supernatant of optimally treated asthmatics: the effect of smoking.

Petta V, Bakakos P, Tseliou E, Kostikas K, Simoes DC, Konstantellou E, Hillas G, Koulouris NG, Papiris S, Loukides S.

Eur J Clin Invest. 2015 Jan;45(1):56-62. doi: 10.1111/eci.12379.

PMID:
25402718
31.

Increased levels of osteopontin in sputum supernatant in patients with COPD.

Papaporfyriou A, Loukides S, Kostikas K, Simoes DCM, Papatheodorou G, Konstantellou E, Hillas G, Papiris S, Koulouris N, Bakakos P.

Chest. 2014 Oct;146(4):951-958. doi: 10.1378/chest.13-2440.

PMID:
24902063
32.

Heart rate recovery post 6-minute walking test in obstructive sleep apnea: cycle ergometry versus 6-minute walking test in OSA patients.

Cholidou KG, Manali ED, Kapsimalis F, Kostakis ID, Vougas K, Simoes D, Markozannes E, Vogiatzis I, Bakakos P, Koulouris N, Alchanatis M.

Clin Res Cardiol. 2014 Oct;103(10):805-15. doi: 10.1007/s00392-014-0721-3. Epub 2014 May 13.

PMID:
24820928
33.

A case of imported Middle East Respiratory Syndrome coronavirus infection and public health response, Greece, April 2014.

Tsiodras S, Baka A, Mentis A, Iliopoulos D, Dedoukou X, Papamavrou G, Karadima S, Emmanouil M, Kossyvakis A, Spanakis N, Pavli A, Maltezou H, Karageorgou A, Spala G, Pitiriga V, Kosmas E, Tsiagklis S, Gkatzias S, Koulouris N, Koutsoukou A, Bakakos P, Markozanhs E, Dionellis G, Pontikis K, Rovina N, Kyriakopoulou M, Efstathiou P, Papadimitriou T, Kremastinou J, Tsakris A, Saroglou G.

Euro Surveill. 2014 Apr 24;19(16):20782. Erratum in: Euro Surveill. 2014;19(17):pii/20786.

34.

Serum angiopoietin-2 and CRP levels during COPD exacerbations.

Nikolakopoulou S, Hillas G, Perrea D, Tentolouris N, Loukides S, Kostikas K, Simoes D, Georgakopoulou E, Vogiatzakis E, Veldekis D, Bakakos P.

COPD. 2014 Feb;11(1):46-51. doi: 10.3109/15412555.2013.829436. Epub 2013 Oct 8.

PMID:
24102428
35.

Biomarkers in COPD: is mortality the Holy Grail?

Kostikas K, Loukides S, Bakakos P.

COPD. 2013 Oct;10(5):557-9. doi: 10.3109/15412555.2013.832092. No abstract available.

PMID:
24040907
36.

Vascular endothelial growth factor and cysteinyl leukotrienes in sputum supernatant of patients with asthma.

Papadaki G, Bakakos P, Kostikas K, Hillas G, Tsilogianni Z, Koulouris NG, Papiris S, Loukides S.

Respir Med. 2013 Sep;107(9):1339-45. doi: 10.1016/j.rmed.2013.06.014. Epub 2013 Jul 8.

37.

Levels of prostaglandin E(2) and Cysteinyl-leukotrienes in sputum supernatant of patients with asthma: the effect of smoking.

Kontogianni K, Bakakos P, Kostikas K, Hillas G, Papaporfyriou A, Papiris S, Koulouris NG, Loukides S.

Clin Exp Allergy. 2013 Jun;43(6):616-24. doi: 10.1111/cea.12077.

PMID:
23711123
38.

Noninvasive evaluation of airway inflammation in patients with severe asthma.

Papaporfyriou A, Tseliou E, Loukides S, Kostikas K, Bakakos P.

Ann Allergy Asthma Immunol. 2013 May;110(5):316-21. doi: 10.1016/j.anai.2012.12.026. Review. No abstract available. Erratum in: Ann Allergy Asthma Immunol. 2013 Aug;111(2):149.

PMID:
23622000
39.

Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment.

Diamanti C, Manali E, Ginieri-Coccossis M, Vougas K, Cholidou K, Markozannes E, Bakakos P, Liappas I, Alchanatis M.

Sleep Breath. 2013 Dec;17(4):1159-68. doi: 10.1007/s11325-013-0815-6. Epub 2013 Feb 6.

PMID:
23386373
40.

Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?

Kostikas K, Bakakos P, Papiris S, Stolz D, Celli BR.

Curr Drug Targets. 2013 Feb;14(2):177-91. Review.

PMID:
23256717
41.

Editorial: COPD management beyond bronchodilation: current targets and future prospects.

Kostikas K, Bakakos P, Loukides S.

Curr Drug Targets. 2013 Feb;14(2):139-40. No abstract available.

PMID:
23256713
42.

Increased levels of osteopontin in sputum supernatant of smoking asthmatics.

Hillas G, Loukides S, Kostikas K, Simoes D, Petta V, Konstantellou E, Emmanouil P, Papiris S, Koulouris N, Bakakos P.

Cytokine. 2013 Jan;61(1):251-5. doi: 10.1016/j.cyto.2012.10.002. Epub 2012 Oct 23.

PMID:
23098767
43.

Levels of angiopoietins 1 and 2 in induced sputum supernatant in patients with COPD.

Bessa V, Loukides S, Hillas G, Delimpoura V, Simoes D, Kontogianni K, Papiris S, Kostikas K, Alchanatis M, Bakakos P.

Cytokine. 2012 Jun;58(3):455-60. doi: 10.1016/j.cyto.2012.03.007. Epub 2012 Apr 6.

PMID:
22483377
44.

Increased levels of angiopoietins 1 and 2 in sputum supernatant in severe refractory asthma.

Tseliou E, Bakakos P, Kostikas K, Hillas G, Mantzouranis K, Emmanouil P, Simoes D, Alchanatis M, Papiris S, Loukides S.

Allergy. 2012 Mar;67(3):396-402. doi: 10.1111/j.1398-9995.2011.02768.x. Epub 2012 Jan 9.

45.

Associations between BODE index and systemic inflammatory biomarkers in COPD.

Gaki E, Kontogianni K, Papaioannou AI, Bakakos P, Gourgoulianis KI, Kostikas K, Alchanatis M, Papiris S, Loukides S.

COPD. 2011 Dec;8(6):408-13. doi: 10.3109/15412555.2011.619599.

PMID:
22149400
46.

The inflammatory effector cell pattern in asthma and chronic obstructive pulmonary disease - what is it good for?

Kroegel C, Bakakos P.

Respiration. 2012;83(1):17-9. doi: 10.1159/000334231. Epub 2011 Nov 22. No abstract available.

47.

Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers.

Papaioannou AI, Loukides S, Minas M, Kontogianni K, Bakakos P, Gourgoulianis KI, Alchanatis M, Papiris S, Kostikas K.

Respir Res. 2011 May 22;12:67. doi: 10.1186/1465-9921-12-67.

48.

Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers.

Hillas G, Kostikas K, Mantzouranis K, Bessa V, Kontogianni K, Papadaki G, Papiris S, Alchanatis M, Loukides S, Bakakos P.

Respirology. 2011 Jul;16(5):811-8. doi: 10.1111/j.1440-1843.2011.01984.x.

PMID:
21545371
49.

Non-invasive assessment of asthmatic inflammation: from bench to bedside.

Loukides S, Kostikas K, Bakakos P.

Curr Med Chem. 2011;18(10):1413-4. No abstract available.

PMID:
21428899
50.

Induced sputum in asthma: from bench to bedside.

Bakakos P, Schleich F, Alchanatis M, Louis R.

Curr Med Chem. 2011;18(10):1415-22. Review.

Supplemental Content

Loading ...
Support Center